Actinium Pharmaceuticals Inc
ATNM
$1.40+6.87%
End of day · as of Sep 12, 2026, 11:46 AM ET
Mkt cap
$33.88M
EV/Sales
-156.81
P/E ratio
N/A
FY2025 Revenue
$90,000
EPS (H1 2026)
$0.71
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-37652.22%
Beta
-0.11
Div yield
N/A
Sector
Healthcare
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Latest reported ATNM revenue for 2025-12-31 was $90.0K. Net income was -$33.9M. Revenue was up 11.1% from 2023-12-31 to 2025-12-31. ATNM currently screens at market cap $33.9M.
Use this ATNM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ATNM income, balance, and cash tables.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company in the Healthcare sector.
Latest cached Actinium Pharmaceuticals Inc (ATNM) revenue for Dec 31, 2025 was $90.0K. Net income was -$33.9M. Statements: https://lician.com/financials/atnm
Actinium Pharmaceuticals Inc (ATNM) market capitalization is $33.9M on the latest cached snapshot.
Actinium Pharmaceuticals Inc (ATNM) cached previous close $1.31; day range $1.29 – $1.42; volume 237,937. Session quote: https://lician.com/quote/atnm
Actinium Pharmaceuticals Inc (ATNM) latest cached earnings event is "ATNM earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ATNM filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/atnm